Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2026-03-03 @ 3:06 PM
Study NCT ID:
NCT00087620
Status:
TERMINATED
Last Update Posted:
2017-02-03
First Post:
2004-07-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-09
Start Date Type:
ACTUAL
Primary Completion Date:
2004-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-10
Completion Date Type:
ACTUAL
First Submit Date:
2004-07-12
First Submit QC Date:
None
Study First Post Date:
2004-07-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-02
Last Update Post Date:
2017-02-03
Last Update Post Date Type:
ESTIMATED